Number: 1419329
Country: Norway
Source: TED
Infection immunology analysis for microbiology.
The procurement comprises analysis for detection of Adenovirus, Bordetella Pertussis, Borrelia, Cytomegalovirus, Epstein-Barr virus, Helicobacter Pylori, Hepatitis B core IgM, Herpes simplex virus, Invasive fungal infection (Beta Glucan and Galactamannan), Malaria, Morbillivirus, Mycobacterium tuberculosis, Parotittvirus, Parvovirus B19, Rotavirus, Syphilis, Toxoplasmose and Varicella Zoster virus. It also includes right of use (hire) of equipment for fully-automated analysis of as many analyses as possible and right of use (hire) of equipment for partial automation of as many of the analyses as possible. See the tender documentation for a more detailed description.
Sub Contract A
Oslo.
Award of contracts will occur on the basis of which combination of tender offers is the most economically advantageous for the Contracting Authority, assessed according to the criteria given in the tender documentation. Several sub contracts may be awarded and the individual sub-contract may include one or more sections.
Sub-contract B
Sub-contract C
Sub-contract D
Sub-contract E
Vestre Viken HF, Akershus universitetssykehus HF and Sykehuset Innlandet HF have an option to join the contract for the analysis TBIGRA (the Mycobacterium tuberculosis analysis) in analysis group 2.11 IGRA.
The option period is 6 months from when OUS is signing own agreement.
Each health trust decides on independent basis if they wants to trigger the option or not.
The option will be taken up by the health company signing a separate contract on the same terms and length as the contract for Oslo universitetssykehus HF.
Infection immunological analyses (other analyses)
Infection immunological analyses (Aspergillus, Malaria, Toxo)
Infection immunological analyses (Epstein Barr Virus — Ullevål)
Infection immunological analyses (HSV and VZV in spinal fluid)
Infection immunological analyses (IGRA)
Contracts have not been awarded for the analyses Bordetella Pertussis, Syphilis IgM (Ullevål) or Beta-glucan, as either tenders were not received or because the offered test was not acceptable.